Osterweis Capital Management Inc. Has $19.28 Million Position in AMETEK, Inc. $AME

Key Points

• Osterweis Capital Management Inc. reduced its holdings in AMETEK, Inc. by 22% in Q1, now owning 112,007 shares worth approximately $19.28 million.
• Other institutional investors significantly increased their positions in AMETEK, with Invesco boosting its stake by 127.2% in Q1.
• AMETEK announced a quarterly dividend of $0.31 per share, set to be paid on September 30th, which represents an annualized yield of 0.7%.

Osterweis Capital Management Inc. lessened its holdings in AMETEK, Inc. (NYSE:AME - Free Report) by 22.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 112,007 shares of the technology company's stock after selling 31,510 shares during the quarter. Osterweis Capital Management Inc.'s holdings in AMETEK were worth $19,281,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of AME. Invesco Ltd. boosted its position in shares of AMETEK by 127.2% in the first quarter. Invesco Ltd. now owns 3,479,397 shares of the technology company's stock valued at $598,943,000 after acquiring an additional 1,947,831 shares during the period. Lazard Asset Management LLC boosted its position in shares of AMETEK by 393.1% in the fourth quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock valued at $219,030,000 after acquiring an additional 968,661 shares during the period. GAMMA Investing LLC boosted its position in shares of AMETEK by 18,368.3% in the first quarter. GAMMA Investing LLC now owns 973,280 shares of the technology company's stock valued at $167,540,000 after acquiring an additional 968,010 shares during the period. Compagnie Lombard Odier SCmA bought a new stake in shares of AMETEK in the first quarter valued at about $113,317,000. Finally, Alteri Wealth LLC bought a new stake in shares of AMETEK in the fourth quarter valued at about $114,769,000. Institutional investors own 87.43% of the company's stock.

AMETEK Stock Up 1.4%

AME stock opened at $185.1580 on Wednesday. The stock has a market capitalization of $42.76 billion, a P/E ratio of 29.82, a price-to-earnings-growth ratio of 2.63 and a beta of 1.10. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33. The firm has a 50-day moving average price of $180.76 and a 200-day moving average price of $176.93.

AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Thursday, July 31st. The technology company reported $1.78 EPS for the quarter, topping analysts' consensus estimates of $1.69 by $0.09. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The firm had revenue of $1.78 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the business earned $1.66 earnings per share. The business's revenue for the quarter was up 2.5% compared to the same quarter last year. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. As a group, equities research analysts anticipate that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

AMETEK Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th will be paid a $0.31 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.24 annualized dividend and a dividend yield of 0.7%. AMETEK's dividend payout ratio is currently 19.97%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AME. Melius Research raised shares of AMETEK to a "hold" rating in a research report on Monday, July 14th. Morgan Stanley upped their price objective on shares of AMETEK from $185.00 to $198.00 and gave the stock an "equal weight" rating in a research report on Friday, August 8th. Truist Financial upped their price objective on shares of AMETEK from $196.00 to $200.00 and gave the stock a "buy" rating in a research report on Monday, May 5th. Mizuho upped their price objective on shares of AMETEK from $212.00 to $225.00 and gave the stock an "outperform" rating in a research report on Friday, August 1st. Finally, Melius cut shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 price objective for the company. in a research report on Monday, July 14th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $208.00.

AMETEK Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.